Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
BBP
63
HOLDINGS
15%
ALSO IN XPH
XPH
55
HOLDINGS
17%
ALSO IN BBP
SECTOR DRIFT (BBP minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
AXSOME THERAPEUTICS, INC. | 2.2% | 2.7% | 2.2% |
|
LIGAND PHARMACEUTICALS-CL B | 1.9% | 1.9% | 1.9% |
 |
THERAVANCE BIOPHARMA INC | 1.5% | 1.3% | 1.3% |
|
ESPERION THERAPEUTICS INC | 1.3% | 2.1% | 1.3% |
|
TARSUS PHARMACEUTICALS, INC. | 1.3% | 1.5% | 1.3% |
BBP Overweight Relative to XPH
|
IMMUNITYBIO INC | 4.8% |
|
APELLIS PHARMACEUTICALS, INC. | 2.6% |
|
KALVISTA PHARMACEUTICALS INC | 2.5% |
|
IOVANCE BIOTHERAPEUTICS INC | 2.5% |
|
MODERNA, INC. | 2.5% |
|
MIRUM PHARMACEUTICALS, INC. | 2.4% |
|
TRAVERE THERAPEUTICS, INC. | 2.0% |
 |
ROIVANT SCIENCES LTD. | 2.0% |
|
NOVAVAX INC | 2.0% |
|
BIOCRYST PHARMACEUTICALS INC | 1.9% |
BBP Underweight Relative to XPH
|
ORGANON & CO. | -3.8% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.9% |
|
DEFINIUM THERAPEUTICS INC | -2.4% |
|
ENLIVEN THERAPEUTICS, INC. | -2.3% |
 |
JAZZ PHARMACEUTICALS PLC | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
TREVI THERAPEUTICS, INC. | -2.1% |
|
VIATRIS, INC. | -2.1% |
|
PERRIGO CO | -2.0% |